Sinovac Biotech Co., Ltd.

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Multi-center, Open-labelled, Randomized, Controlled, Extended Phase Ⅲ Clinical Trial of sIPV Vaccine

Phase 3

Recruiting

Conditions: Poliomyelitis
Polio

Interventions: Biological: Sabin Strain Inactivated Poliovirus Vaccine

First Posted Date: 2023-05-09

Last Posted Date: 2023-09-26

Lead Sponsor: Sinovac Biotech Co., Ltd

Target Recruit Count: 1440

Registration Number: NCT05850364

Locations: 🇵🇰
Central Hospital, Gujranwala, Pakistan
🇧🇩
International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh
🇵🇰
The Aga Khan University, Karachi, Pakistan

Lot-to-lot Consistency of 23-valent Pneumococcal Polysaccharide Vaccine

Phase 4

Completed

Conditions: Pneumococcal Infections

Interventions: Biological: Experimental 23-valent Pneumococcal

First Posted Date: 2023-02-16

Last Posted Date: 2023-09-18

Lead Sponsor: Sinovac Biotech Co., Ltd

Target Recruit Count: 1800

Registration Number: NCT05731115

Locations: 🇨🇳
The First People's Hospital of Yuanping Medical Group, Yuanping, Shanxi, China
🇨🇳
Salt Lake District Center for Disease Control and Prevention, Yuncheng, Shanxi, China

A Serosurvey Study of Hand, Foot, and Mouth Disease in Indonesia

Completed

Conditions: Hand, Foot and Mouth Disease

First Posted Date: 2022-12-05

Last Posted Date: 2023-10-31

Lead Sponsor: Sinovac Biotech Co., Ltd

Target Recruit Count: 600

Registration Number: NCT05637229

Locations: 🇮🇩
Padalarang Health Center, Bandung, Indonesia
🇮🇩
Garuda Health Center, Bandung, Indonesia

Lot-to-lot Consistency of Quadrivalent Influenza Vaccine (Split Virion), Inactivated

Phase 4

Completed

Conditions: Seasonal Influenza

Interventions: Biological: Quadrivalent Influenza Vaccine (Split Virion), inactivated

First Posted Date: 2022-08-23

Last Posted Date: 2023-09-18

Lead Sponsor: Sinovac Biotech Co., Ltd

Target Recruit Count: 1260

Registration Number: NCT05512494

Locations: 🇨🇳
Yuping Dong Autonomous County Center for Disease Control and Prevention, Zhumadian, Guizhou, China

A Study of Booster Immunization With COVID-19 Vaccine,Inactivated Co -Administration With Influenza Vaccine and Pneumococcal Polysaccharide Vaccine

Phase 4

Completed

Conditions: COVID-19

Interventions: Biological: Elderly group in immunogenicity and safety study of combined immunization
Biological: Adult group in immunogenicity and safety study of combined immunization
Biological: Adult group in safety observation study of combined immunization
Biological: Elderly group in safety observation study of combined immunization

First Posted Date: 2022-08-12

Last Posted Date: 2022-08-12

Lead Sponsor: Sinovac Biotech Co., Ltd

Target Recruit Count: 3000

Registration Number: NCT05499351

Locations: 🇨🇳
Beijing Centers for Diseases Control and Prevention, Beijing, China

Immunogenicity and Safety of 23-valent Pneumococcal Polysaccharide Vaccine

Phase 4

Completed

Conditions: Pneumococcal Infections

Interventions: Biological: Experimental 23-valent PPV
Biological: Control 23-valent PPV

First Posted Date: 2022-07-28

Last Posted Date: 2023-09-18

Lead Sponsor: Sinovac Biotech Co., Ltd

Target Recruit Count: 1800

Registration Number: NCT05477693

Locations: 🇨🇳
Linwei District Center for Disease Control and Prevention, Weinan, Shanxi, China

Study on Combined Vaccination With Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine

Phase 4

Completed

Conditions: Influenza and Pneumonia

Interventions: Biological: Combined vaccination with quadrivalent influenza vaccine and 23-valent pneumococcal polysaccharide vaccine
Biological: Separate vaccination with quadrivalent influenza vaccine and 23-valent pneumococcal polysaccharide vaccine

First Posted Date: 2022-07-25

Last Posted Date: 2022-07-25

Lead Sponsor: Sinovac Biotech Co., Ltd

Target Recruit Count: 3000

Registration Number: NCT05471531

Locations: 🇨🇳
Taizhou City Hospital of Traditional Chinese and Western Medicine, Taizhou, Jiangsu, China
🇨🇳
Gaogang District Center for Disease Control and Prevention, Taizhou, Jiangsu, China
🇨🇳
Xinghua Center for Disease Control and Prevention, Taizhou, Jiangsu, China

and more 1 locations

A Safety Study of Sabin Inactivated Poliovirus Vaccine in Infants

Phase 4

Completed

Conditions: Poliomyelitis

Interventions: Biological: sIPV vaccine /DTaP vaccine
Biological: sIPV vaccine /Hepatitis A inactivated vaccine /MMR vaccine

First Posted Date: 2022-06-27

Last Posted Date: 2023-01-12

Lead Sponsor: Sinovac Biotech Co., Ltd

Target Recruit Count: 3200

Registration Number: NCT05432141

Locations: 🇨🇳
Shangli County Center for Disease Control and Prevention, Pingxiang, Jiangxi, China
🇨🇳
Gaoan Center for Disease Control and Prevention, Gao'an, Jiangxi, China

Immunogenicity and Safety Study of Influenza Vaccine (Split Virion), Inactivated, Quadrivalent

Phase 3

Completed

Conditions: Seasonal Influenza

Interventions: Biological: Influenza Vaccine (Split Virion), Inactivated, Quadrivalent
Biological: Control Quadrivalent influenza virus vaccine

First Posted Date: 2022-06-24

Last Posted Date: 2024-05-28

Lead Sponsor: Sinovac Biotech Co., Ltd

Target Recruit Count: 2202

Registration Number: NCT05431725

Locations: 🇨🇱
Universidad San Sebastián, Santiago, Chile
🇵🇭
Las Pinas Doctors Hospital, Las Pinas, Manila, Philippines
🇵🇭
Philippine General Hospital, Manila, Philippines

and more 8 locations

An Immunity Persistence Study of Enterovirus 71 Inactivated Vaccine (Vero Cell)

Phase 4

Not yet recruiting

Conditions: Hand, Foot and Mouth Disease

Interventions: Biological: Control Vaccine
Biological: Experimental Vaccine

First Posted Date: 2022-05-31

Last Posted Date: 2022-06-10

Lead Sponsor: Sinovac Biotech Co., Ltd

Target Recruit Count: 474

Registration Number: NCT05397587

Locations: 🇨🇳
Yun County Center for Disease Control and Prevention, Lincang, Yunnan, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy